Lexicon Pharmaceuticals (NASDAQ:LXRX) said that the FDA has asked for additional time to review additional data for the potential resubmission of the marketing application for Zynquista (sotagliflozin ...

THE WOODLANDS, Texas, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced an update to the previous submission of additional clinical data to the U.S. Food ...

A new face is lighting up hospitals and nursing homes across the country. It’s an animated, cartoonish persona displayed on a digital screen roughly the size of an iPad, mounted on top of a robotic ...

THE WOODLANDS, Texas - Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), a pharmaceutical company with a current market capitalization of $396 million, has submitted additional clinical data to the U.S.

(Reuters) -Lexicon Pharmaceuticals said on Monday the U.S. Food and Drug Administration requires more time to review the company's previously submitted additional data on its experimental drug, ...

Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable ...

Geoff (He/Him) is a Contributor from Canada. He has been playing games since he walked into a random apartment with a super nintendo as a child with Super Mario World already inserted. Geoff has ...

The ‘photorealistic’ avatar can help cover up your bedhead. The ‘photorealistic’ avatar can help cover up your bedhead. is a news writer who covers the streaming wars, consumer tech, crypto, social ...

Former WWE star Shanky Singh recently shared his experience of meeting with The Undertaker. He had a chance to connect with the legendary wrestling during his time in the company. Shanky had a ...

Mark Hospodar has been an avid gamer ever since he fired up the original Medal of Honor on his PS1. A history teacher by training, Mark has branched out into the fields of fiction and non-fiction ...